Related Entries


February 22, 2022 | POLICY & RESEARCH

ICYMI: Navigating the Medical Marijuana Landscape — Virtual Event (February 22, 2022)

Thirty-seven states (as of February 2, 2022) and the District of Columbia have approved comprehensive, publicly available medical marijuana/cannabis programs, while 11 states allow the use of "low THC, high cannabidiol (CBD)" products for medical reasons in limited situations or as a legal defense. On February 22, 2022, the Kansas Health Institute (KHI) hosted a virtual discussion about policy issues related to medical marijuana and compared laws in other states with provisions in two Kansas bills.

Read More
November 05, 2021 | POLICY & RESEARCH

A Kansas Twist — Digging into State Medical Marijuana Laws (November 5, 2021)

In 2021, the Kansas House passed House Substitute for Senate Bill (SB) 158, which would create the Kansas Medical Marijuana Regulation Act and the Kansas Medical Marijuana Regulation Program. While the Senate did not work the bill in 2021, it remains alive for consideration during the 2022 session, along with a similar bill, SB 315. This edition of A Kansas Twist discusses elements of the Kansas bills in the context of medical marijuana laws in other states.

Read More
April 01, 2019 | POLICY & RESEARCH

Medical Marijuana: Policy Considerations (April 2019)

Thirty-four states have legalized marijuana for a broad range of medical purposes. Ten of those states also have legalized recreational use for adults, thereby creating conflicts between state and federal laws in an environment of evolving research regarding therapeutic benefits of medical marijuana and risks to public health. Twelve states have limited medical marijuana use laws. This issue brief provides an update to a comprehensive Health Impact Assessment on medical marijuana published by the Kansas Health Institute in 2015.

Read More

Page 1 of 1 pages